Tapemark Gains Registration For Controlled Substances Manufacturing

Tapemark (West St. Paul, MN) announced it is now DEA registered as a Schedule III – V Manufacturer of Controlled Substances. The Drug Enforcement Administration granted the registration following a successful inspection. It is effective immediately.
 
Andy Rensink, president and COO of Tapemark, notes, “We are very excited to enter the market for controlled substances, which represents an elite level of pharmaceutical manufacturing. Our ability to manufacture Schedule III – V Controlled Substances brings a wealth of new opportunities to Tapemark, with our first customer project already underway. We believe this further differentiates Tapemark as the industry-leading contract manufacturer for the pharmaceutical and medical device markets.”
 
The company also announced it has received certification to produce medical devices for Japan. And in addition, Tapemark announced it has received certification to the updated ISO standard, ISO 9001:2008.